Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation?
- PMID: 36614020
- PMCID: PMC9820159
- DOI: 10.3390/ijms24010578
Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation?
Abstract
Depression is one of the leading mental illnesses worldwide and lowers the quality of life of many. According to WHO, about 5% of the worldwide population suffers from depression. Newer studies report a staggering global prevalence of 27.6%, and it is rising. Professionally, depression belonging to affective disorders is a psychiatric illness, and the category of major depressive disorder (MDD) comprises various diagnoses related to persistent and disruptive mood disorders. Due to this fact, it is imperative to find a way to assess depression quantitatively using a specific biomarker or a panel of biomarkers that would be able to reflect the patients' state and the effects of therapy. Cytokines, hormones, oxidative stress markers, and neuropeptides are studied in association with depression. The latest research into inflammatory cytokines shows that their relationship with the etiology of depression is causative. There are stronger cytokine reactions to pathogens and stressors in depression. If combined with other predisposing factors, responses lead to prolonged inflammatory processes, prolonged dysregulation of various axes, stress, pain, mood changes, anxiety, and depression. This review focuses on the most recent data on cytokines as markers of depression concerning their roles in its pathogenesis, their possible use in diagnosis and management, their different levels in bodily fluids, and their similarities in animal studies. However, cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders. Their effects are only a part of the whole pathway.
Keywords: IL-12; IL-1β; TNF; chemokines; cytokines; depression; interleukins; lymphokines.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899. Turk Psikiyatri Derg. 2021. PMID: 34964106 English, Turkish.
-
Acute stress response to a cognitive task in patients with major depressive disorder: potential metabolic and proinflammatory biomarkers.Metab Brain Dis. 2019 Apr;34(2):621-629. doi: 10.1007/s11011-018-0367-3. Epub 2018 Dec 18. Metab Brain Dis. 2019. PMID: 30564974
-
Molecular Biomarkers for Pediatric Depressive Disorders: A Narrative Review.Int J Mol Sci. 2021 Sep 17;22(18):10051. doi: 10.3390/ijms221810051. Int J Mol Sci. 2021. PMID: 34576215 Free PMC article. Review.
-
The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.J Affect Disord. 2018 Jun;233:15-20. doi: 10.1016/j.jad.2017.06.001. Epub 2017 Jun 6. J Affect Disord. 2018. PMID: 28633757
-
Brain-derived neurotrophic factor (BDNF) and inflammatory markers: Perspectives for the management of depression.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110151. doi: 10.1016/j.pnpbp.2020.110151. Epub 2020 Oct 21. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33096156 Review.
Cited by
-
Salvia elegans Vahl Counteracting Metabolic Syndrome and Depression in Mice on a High-Fat Diet.Molecules. 2024 Aug 28;29(17):4070. doi: 10.3390/molecules29174070. Molecules. 2024. PMID: 39274918 Free PMC article.
-
Inflammatory biomarkers in depression: scoping review.BJPsych Open. 2024 Sep 30;10(5):e165. doi: 10.1192/bjo.2024.787. BJPsych Open. 2024. PMID: 39343996 Free PMC article.
-
Circulating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study.JAMA Psychiatry. 2025 May 1;82(5):481-491. doi: 10.1001/jamapsychiatry.2025.0033. JAMA Psychiatry. 2025. PMID: 40072421
-
Association between methylmalonic acid and prevalence of depression in US adults: evidence from NHANES 2011-2014.Eur J Psychotraumatol. 2025 Dec;16(1):2450109. doi: 10.1080/20008066.2025.2450109. Epub 2025 Feb 13. Eur J Psychotraumatol. 2025. PMID: 39943880 Free PMC article.
-
Modulating depression through the gut-brain axis: the role of gut microbiota in therapeutic interventions.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 21. doi: 10.1007/s00210-025-04464-6. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40690011 Review.
References
-
- Depression. [(accessed on 29 November 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/depression.
-
- Santomauro D.F., Herrera A.M.M., Shadid J., Zheng P., Ashbaugh C., Pigott D.M., Abbafati C., Adolph C., Amlag J.O., Aravkin A.Y., et al. Global Prevalence and Burden of Depressive and Anxiety Disorders in 204 Countries and Territories in 2020 Due to the COVID-19 Pandemic. Lancet. 2021;398:1700–1712. doi: 10.1016/S0140-6736(21)02143-7. - DOI - PMC - PubMed
-
- Kola L., Kohrt B.A., Hanlon C., Naslund J.A., Sikander S., Balaji M., Benjet C., Cheung E.Y.L., Eaton J., Gonsalves P., et al. COVID-19 Mental Health Impact and Responses in Low-Income and Middle-Income Countries: Reimagining Global Mental Health. Lancet Psychiatry. 2021;8:535–550. doi: 10.1016/S2215-0366(21)00025-0. - DOI - PMC - PubMed
-
- Bains N., Abdijadid S. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Major Depressive Disorder. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources